Published in Am J Ophthalmol on August 07, 2009
Sympathetic ophthalmia: what have we learned? Am J Ophthalmol (2009) 1.73
Reversible retinal changes in the acute stage of sympathetic ophthalmia seen on spectral domain optical coherence tomography. Int Ophthalmol (2011) 1.26
Sympathetic ophthalmia: to the twenty-first century and beyond. J Ophthalmic Inflamm Infect (2013) 1.25
Sympathetic ophthalmia following postoperative endophthalmitis and evisceration. Hippokratia (2010) 0.78
Reversible alopecia in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. J Ophthalmic Inflamm Infect (2013) 0.76
Gender differences in vogt-koyanagi-harada disease and sympathetic ophthalmia. J Ophthalmol (2014) 0.76
Gender disparities in ocular inflammatory disorders. Curr Eye Res (2014) 0.75
A rare case of atypical sympathetic ophthalmia post therapeutic keratoplasty. J Ophthalmic Inflamm Infect (2016) 0.75
Characteristics of Sympathetic Ophthalmia in a Single International Center. Open Ophthalmol J (2016) 0.75
Sympathetic ophthalmitis following vitreoretinal surgery: Does antecedent trauma make a difference? Indian J Ophthalmol (2015) 0.75
[Sympathetic ophthalmia following repeated pars plana vitrectomy : Clinical findings and spectral domain OCT follow-up]. Ophthalmologe (2017) 0.75
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol (2007) 8.12
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol (2009) 5.41
Three-year follow-up of the tube versus trabeculectomy study. Am J Ophthalmol (2009) 4.21
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol (2012) 3.93
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol (2011) 3.79
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina (2006) 3.48
Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina (2014) 3.41
Evolving guidelines for intravitreous injections. Retina (2004) 3.39
Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol (2004) 2.98
Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina (2011) 2.97
Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol (2006) 2.94
Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol (2013) 2.90
Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma. Ophthalmology (2013) 2.83
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol (2012) 2.82
Reproducibility of peripapillary retinal nerve fiber thickness measurements with stratus OCT in glaucomatous eyes. Ophthalmology (2007) 2.75
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol (2006) 2.73
Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology (2010) 2.68
Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol (2005) 2.66
Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology (2004) 2.63
Macular ganglion cell-inner plexiform layer: automated detection and thickness reproducibility with spectral domain-optical coherence tomography in glaucoma. Invest Ophthalmol Vis Sci (2011) 2.46
Comparison of retinal nerve fiber layer measurements using time domain and spectral domain optical coherent tomography. Ophthalmology (2009) 2.41
Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology (2012) 2.41
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23
Evaluation of patients with scleritis for systemic disease. Ophthalmology (2004) 2.22
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV. Graefes Arch Clin Exp Ophthalmol (2010) 2.16
Retained lens fragments after cataract surgery: outcomes of same-day versus later pars plana vitrectomy. Am J Ophthalmol (2013) 2.13
Pars plana vitrectomy for vitreous floaters: is there such a thing as minimally invasive vitreoretinal surgery? Retina (2014) 2.11
The diagnostic utility of anterior chamber paracentesis with polymerase chain reaction in anterior uveitis. Am J Ophthalmol (2013) 2.08
Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist (2011) 2.05
Telephotoscreening to detect retinopathy of prematurity: preliminary study of the optimum time to employ digital fundus camera imaging to detect ROP. J AAPOS (2002) 2.03
Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol (2009) 2.02
Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma. Ophthalmology (2011) 2.01
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology (2011) 2.00
Visual and anatomical outcomes of macular epiretinal membrane peeling after previous rhegmatogenous retinal detachment repair. Retina (2015) 1.98
Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology (2011) 1.96
The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol (2004) 1.95
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology (2010) 1.93
Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol (2011) 1.92
Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol (2004) 1.91
Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol (2004) 1.91
Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol (2007) 1.89
Outcomes of sulfur hexafluoride (SF6) versus perfluoropropane (C3F8) gas tamponade for macular hole surgery. Retina (2008) 1.89
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina (2002) 1.86
Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol (2009) 1.83
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol (2010) 1.83
Delayed- versus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol (2011) 1.83
Pattern electroretinogram abnormality and glaucoma. Ophthalmology (2005) 1.82
Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002-2009). Am J Ophthalmol (2010) 1.82
Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology (2002) 1.81
Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Am J Ophthalmol (2006) 1.80
Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology (2007) 1.79
Reproducibility of peripapillary retinal nerve fiber layer thickness and optic nerve head parameters measured with cirrus HD-OCT in glaucomatous eyes. Invest Ophthalmol Vis Sci (2010) 1.77
Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina (2008) 1.75
The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med (2005) 1.75
Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol (2004) 1.74
Evaluation of patients with dry eye for presence of underlying Sjögren syndrome. Cornea (2009) 1.69
Acute macular neuroretinopathy: long-term insights revealed by multimodal imaging. Retina (2012) 1.68
Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol (2007) 1.66
Scanning laser polarimetry with variable and enhanced corneal compensation in normal and glaucomatous eyes. Am J Ophthalmol (2006) 1.62
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
The effect of optic disk edema on spontaneous venous pulsations. Am J Ophthalmol (2003) 1.60
Effect of race, age, and axial length on optic nerve head parameters and retinal nerve fiber layer thickness measured by Cirrus HD-OCT. Arch Ophthalmol (2012) 1.59
Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58
ENDOPHTHALMITIS CAUSED BY PSEUDOMONAS AERUGINOSA: Clinical Features, Antibiotic Susceptibilities, and Treatment Outcomes. Retina (2015) 1.58
Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina (2008) 1.57
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Sensitivity and specificity of time-domain versus spectral-domain optical coherence tomography in diagnosing early to moderate glaucoma. Ophthalmology (2009) 1.55
Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology (2010) 1.54
Photoreceptor inner/outer segment defect imaging by spectral domain OCT and visual prognosis after macular hole surgery. Invest Ophthalmol Vis Sci (2009) 1.54
The tube versus trabeculectomy study: design and baseline characteristics of study patients. Am J Ophthalmol (2005) 1.53
Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology (2013) 1.51
Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology (2008) 1.51
The relationship between retinal ganglion cell function and retinal nerve fiber thickness in early glaucoma. Invest Ophthalmol Vis Sci (2006) 1.50
Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol (2009) 1.48